Benchmark indices were trading higher amid high volatility. Pharma, auto, IT stocks gain in trade, up by 1%. BSE Midcap and Smallcap indices are up over 0.8% each, outperforming the major indices. Gaurav Garg of Capital Via Global research spoke to Money9 on where will money be made in markets now.
“Markets have been flat and range-bound in July series. Results have not been able to give markets a fresh trigger to break out of the range. Institutional investors are still bullish as seen in the rollover data. I expect new highs being hit in the August series”, he said
He believes the demand has improved post the second lockdown now so in Q2, earnings should reflect that.
On new robust listings including Tatva Chintan IPO and the robust listing, he said that the company was a value buy IPO as had attractive PE and even now the stock has further potential.
“One can look at Rs 2800 on Tatva Chintan over next 6-12 months”, he added.
Jubilant Food |Buy | Target: 4500 | 18 months
SRF |Buy | Target: 9900 | 18 months
L&T |Buy | Target: 1900 | 15 months
(Follow Money9 for latest Personal finance stories and Market Updates)
These nudges may seem insignificant at start, but once applied may prove powerful enough to achieve the impossible
Govt must procure just as much as it needs to meet requirements of consumers entitled to rationed grains plus a buffer for contingencies like Covid-19
One of the key issues with MSPs is that they distort production decisions as many farmers grow wheat because of the assured returns on its cultivation
Small savings banks & their participation will most certainly lead to greater competition in the space — and this competition may lead to consequences